Related Experiment Video
Updated: Mar 26, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor
Ivan Casaburi1, Maria Grazia Cesario1, Ada Donà1
1Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), Italy.
Abstract:
Although the protective role of androgen receptor (AR) in breast cancer (BC) is well established, the mechanisms involved remains largely unexplored. MicroRNAs play fundamental roles in many biological processes, including tumor cell development and metastasis. Herein, we report that androgens reduce BC cells proliferation acting as a negative modulator of the onco-miRNA-21.The synthetic androgen miboleron (Mib) decreases BC cell proliferation induced by miR-21 over-expression and AR knockdown evidenced the requirement of AR in the down-regulation of miR-21 expression. These effects seem to be a general mechanism occurring in BC tissues.Chromatin immune-precipitation (ChIP) analysis disclosed the binding of AR to a specific ARE sequence in miR-21 proximal promoter and recognizes the recruitment of HDAC3 as component for AR-mediated transcriptional repression. Such event is associated to a significantly reduced PolII binding in Mib treated extracts confirming that activated AR is a transcriptional repressor of miR-21 expression, providing further insight into the protective role of androgens in breast cancer cells.Collectively, our data and the widespread AR expression in primary and metastatic breast tumours, suggest a careful examination of the therapeutic potential of androgens also in potentiating the effectiveness of anti-oestrogen adjuvant therapies.
Insights
Androgens, specifically through the androgen receptor (AR), inhibit breast cancer cell growth by suppressing onco-microRNA-21 (miR-21). This discovery offers new insights into the protective role of androgens in breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- The androgen receptor (AR) has a known protective role in breast cancer (BC), but the underlying mechanisms are not fully understood.
- MicroRNAs are crucial regulators of cellular processes, including cancer development and metastasis.
Purpose of the Study:
- To investigate the role of androgens and the androgen receptor (AR) in modulating microRNA expression in breast cancer.
- To elucidate the mechanism by which androgens suppress breast cancer cell proliferation via microRNA-21 (miR-21).
Main Methods:
- Utilized synthetic androgen miboleron (Mib) and AR knockdown in breast cancer cells.
- Performed chromatin immunoprecipitation (ChIP) assays to identify AR binding sites.
- Assessed PolII binding and miR-21 expression levels.
Main Results:
- Androgens, via AR, act as negative modulators of the onco-miRNA-21.
- Miboleron treatment decreased BC cell proliferation and miR-21 expression.
- AR binds to the miR-21 promoter, recruiting HDAC3 and repressing transcription, confirmed by reduced PolII binding.
Conclusions:
- Activated AR functions as a transcriptional repressor of miR-21 expression in breast cancer cells.
- Androgens demonstrate a protective role in breast cancer by downregulating miR-21.
- Further research into the therapeutic potential of androgens is warranted, particularly in combination with anti-estrogen therapies.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle

